Skip to content
10-Q

Quarterly Report

BIOVIE INC. BIVI BIVIW

0001520138-24-000425

← back to feed
Filed
Nov 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Nov 7, 2024 17.77M sh
Cash And Equivalents Q1 2024 · Sep 30, 2024 $20.02M
Cash And Equivalents Q1 2024 · Jun 30, 2024 $23.84M
Current Liabilities Q1 2024 · Sep 30, 2024 $6.84M
Current Liabilities Q1 2024 · Jun 30, 2024 $9.35M
Total Liabilities Q1 2024 · Sep 30, 2024 $7.17M
Total Liabilities Q1 2024 · Jun 30, 2024 $9.7M
Current Assets Q1 2024 · Sep 30, 2024 $20.15M
Current Assets Q1 2024 · Jun 30, 2024 $24.05M
Total Assets Q1 2024 · Sep 30, 2024 $21.24M
Total Assets Q1 2024 · Jun 30, 2024 $25.21M
Shares Diluted restated Q1 2024 · Sep 30, 2023 3.67M sh
Operating Cash Flow Q1 2024 · Sep 30, 2023 −$12.18M
Stockholders Equity Q1 2024 · Sep 30, 2023 $7.55M
Stockholders Equity Q1 2024 · Jun 30, 2023 $15.34M
Eps Diluted restated Q1 2024 · Sep 30, 2023 −$2.92
Eps Basic restated Q1 2024 · Sep 30, 2023 −$2.92
Sga Expense Q1 2024 · Sep 30, 2023 $1.94M
Rd Expense Q1 2024 · Sep 30, 2023 $8.88M
Net Income Q1 2024 · Sep 30, 2023 −$10.71M
Operating Income Q1 2024 · Sep 30, 2023 −$10.88M